Financial distress threatens not only the institution, but patient safety and clinical quality as well. To successfully restructure and improve performance, it’s necessary to balance financial, operational and clinical issues.
Do what you do best.
If your organization is struggling, we’ll work alongside your leaders or in interim roles to manage the turnaround process and constituency relations, and drive financial and operating performance, so you can continue to focus on patient health.
We advise companies and creditors, both in and out of court, on balancing patient needs, regulatory compliance and revenue enhancement.
A&M continues to grow Private Equity Performance Improvement business in Europe
June 26, 2025
David Pérez joins to expand the firm’s commercial due diligence capabilities, deepen healthcare sector expertise and bolster the Nordic footprint.
Impending Medicaid Funding Reductions — Strategic Implications for Health Plans
June 11, 2025
In a recent article, A&M Healthcare Industry Group experts explore key policy changes, market dynamics, stakeholder implications and strategic actions for navigating the evolving landscape surrounding the Affordable Care Act marketplace.
Disruption in the ACA Market – Implications and Strategic Responses
June 11, 2025
In a recent article, A&M Healthcare Industry Group experts explore key policy changes, market dynamics, stakeholder implications and strategic actions for navigating the evolving landscape surrounding the Affordable Care Act marketplace.
Alvarez & Marsal's Healthcare Industry Group Appoints Roger Weems as a Managing Director
June 4, 2025
A&M welcomes Roger Weems as a Managing Director in its Healthcare Industry Group within its Health Systems Practice. Mr. Weems' joining advances their firm's ability to support hospitals and health systems with large scale, operational and financial transformation.